In this video, Fabio Malavasi, MD, of the University of Turin, Turin, Italy, discusses immunotherapy in multiple myeloma (MM) from the 1st European Myeloma Network Meeting (EMN) 2018, in Turin, Italy. Prof. Malavasi highlights the innovative apporach of CAR T-cells, before mentioning the current limitations preventing the further development and application of this treatment.
CAR T-cells for mulitple myeloma
